Three studies highlight how proteins are altered in multiple cancer types
Researchers identify protein modifications that underlie many key cancer processes.
This work was supported by the Clinical Proteomic Tumor Analysis Consortium at the National Cancer Institute and the National Institutes of Health.
Geffen Y, Anand S, Akiyama Y, Yaron TM, Song Y, et al. Pan-Cancer analysis of post-translational modifications reveals shared patterns of protein regulation. Cell. Online August 14, 2023. DOI:10.1016/j.cell.2023.07.013
Li Y, Porta-Pardo E, Tokheim C, Bailey MH, Yaron TM, et al. Pan-Cancer proteogenomics connects oncogenic drivers to functional states. Cell. Online August 14, 2023. DOI: 10.1016/j.cell.2023.07.014
Liang WW, et al. Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin. Cancer Cell. Online August 14, 2023. DOI: 10.1016/j.ccell.2023.07.013
Li Y, et al. Proteogenomic data and resources for pan-cancer analysis. Cancer Cell. Online August 14, 2023. DOI: 10.1016/j.ccell.2023.06.009